Adam Savitz - Jul 9, 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Stock symbol
ANRO
Transactions as of
Jul 9, 2024
Transactions value $
$190,833
Form type
4
Date filed
7/11/2024, 04:15 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANRO Common Stock Purchase $134K +10.7K +42.98% $12.53* 35.5K Jul 9, 2024 By Trust F1, F2
transaction ANRO Common Stock Purchase $18.3K +1.39K +3.91% $13.15* 36.9K Jul 9, 2024 By Trust F2
transaction ANRO Common Stock Purchase $38.7K +2.93K +7.94% $13.22* 39.9K Jul 10, 2024 By Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.05 to $13.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.04 to $13.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.